CZ20023A3 - Kombinovaný přípravek k prevenci svalové únavy a přizpůsobení kosterního svalstva na vyčerpávající výkony - Google Patents

Kombinovaný přípravek k prevenci svalové únavy a přizpůsobení kosterního svalstva na vyčerpávající výkony Download PDF

Info

Publication number: CZ20023A3
Authority: CZ; Czechia
Prior art keywords: composition; glyphosate; formulation; ammonium; formulations
Prior art date: 1999-07-23

Application number

CZ20023A

Other languages

Czech (cs)

English (en)

Inventor

Claudio Cavazza

Original Assignee

Sigma-Tau Healthscience S. P. A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-23

Filing date

2000-07-21

Publication date

2002-06-12

2000-07-21 Application filed by Sigma-Tau Healthscience S. P. A. filed Critical Sigma-Tau Healthscience S. P. A.

2002-06-12 Publication of CZ20023A3 publication Critical patent/CZ20023A3/cs

Links

239000000203 mixture Substances 0.000 title claims abstract description 287
230000002265 prevention Effects 0.000 title abstract description 6
150000001875 compounds Chemical class 0.000 title description 8
206010049565 Muscle fatigue Diseases 0.000 title description 7
230000006978 adaptation Effects 0.000 title 1
-1 alkanoyl L-carnitine Chemical compound 0.000 claims abstract description 22
XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 claims description 140
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 77
230000002363 herbicidal effect Effects 0.000 claims description 49
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
238000003860 storage Methods 0.000 claims description 37
239000004094 surface-active agent Substances 0.000 claims description 35
238000000034 method Methods 0.000 claims description 33
229910021529 ammonia Inorganic materials 0.000 claims description 29
239000002253 acid Substances 0.000 claims description 25
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 22
229910052921 ammonium sulfate Inorganic materials 0.000 claims description 22
235000011130 ammonium sulphate Nutrition 0.000 claims description 22
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 22
229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 16
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 8
239000003093 cationic surfactant Substances 0.000 claims description 8
125000000217 alkyl group Chemical group 0.000 claims description 7
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 6
150000003973 alkyl amines Chemical class 0.000 claims description 5
229910052757 nitrogen Inorganic materials 0.000 claims description 5
239000002736 nonionic surfactant Substances 0.000 claims description 5
150000003863 ammonium salts Chemical class 0.000 claims description 4
IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 claims description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
239000005561 Glufosinate Substances 0.000 claims description 2
150000005215 alkyl ethers Chemical class 0.000 claims description 2
125000005211 alkyl trimethyl ammonium group Chemical group 0.000 claims description 2
125000002091 cationic group Chemical group 0.000 claims description 2
238000007865 diluting Methods 0.000 claims description 2
150000003333 secondary alcohols Chemical class 0.000 claims description 2
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 3
241000283011 Rangifer Species 0.000 claims 2
MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 claims 1
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical class CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 1
125000005210 alkyl ammonium group Chemical group 0.000 claims 1
239000012141 concentrate Substances 0.000 claims 1
230000001276 controlling effect Effects 0.000 claims 1
125000004433 nitrogen atom Chemical group N* 0.000 claims 1
230000001105 regulatory effect Effects 0.000 claims 1
PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract description 34
FOIPWTMKYXWFGC-UHFFFAOYSA-N creatinolfosfate Chemical compound NC(=N)N(C)CCOP(O)(O)=O FOIPWTMKYXWFGC-UHFFFAOYSA-N 0.000 abstract description 27
229960002956 creatinolfosfate Drugs 0.000 abstract description 26
238000011282 treatment Methods 0.000 abstract description 15
206010003549 asthenia Diseases 0.000 abstract description 6
230000003387 muscular Effects 0.000 abstract description 4
239000004480 active ingredient Substances 0.000 abstract description 3
230000007812 deficiency Effects 0.000 abstract description 3
235000015872 dietary supplement Nutrition 0.000 abstract description 3
239000003814 drug Substances 0.000 abstract description 3
235000005911 diet Nutrition 0.000 abstract 1
230000000378 dietary effect Effects 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
238000009472 formulation Methods 0.000 description 174
241000196324 Embryophyta Species 0.000 description 74
239000005562 Glyphosate Substances 0.000 description 58
229940097068 glyphosate Drugs 0.000 description 58
239000000243 solution Substances 0.000 description 58
238000012360 testing method Methods 0.000 description 43
PDYXIVPKOMYDOK-UHFFFAOYSA-N Glyphosate-monoammonium Chemical compound [NH4+].OC(=O)CNCP(O)([O-])=O PDYXIVPKOMYDOK-UHFFFAOYSA-N 0.000 description 38
DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 30
239000004009 herbicide Substances 0.000 description 24
230000005764 inhibitory process Effects 0.000 description 22
238000002156 mixing Methods 0.000 description 22
239000013078 crystal Substances 0.000 description 21
210000003205 muscle Anatomy 0.000 description 21
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 20
238000005191 phase separation Methods 0.000 description 20
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 19
238000002360 preparation method Methods 0.000 description 19
238000005507 spraying Methods 0.000 description 18
239000002689 soil Substances 0.000 description 16
230000012010 growth Effects 0.000 description 15
230000015572 biosynthetic process Effects 0.000 description 13
150000003839 salts Chemical class 0.000 description 12
230000000694 effects Effects 0.000 description 11
238000010561 standard procedure Methods 0.000 description 11
239000000126 substance Substances 0.000 description 11
229960003624 creatine Drugs 0.000 description 10
239000006046 creatine Substances 0.000 description 10
241000195950 Equisetum arvense Species 0.000 description 9
230000008569 process Effects 0.000 description 9
239000005768 Equisetum arvense L. Substances 0.000 description 8
241001465754 Metazoa Species 0.000 description 8
235000003621 Solidago canadensis var scabra Nutrition 0.000 description 8
240000003774 Solidago canadensis var. scabra Species 0.000 description 8
239000007921 spray Substances 0.000 description 8
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 8
206010021143 Hypoxia Diseases 0.000 description 7
229910019142 PO4 Inorganic materials 0.000 description 7
235000005247 Rumex japonicus Nutrition 0.000 description 7
244000189123 Rumex japonicus Species 0.000 description 7
230000007954 hypoxia Effects 0.000 description 7
235000021317 phosphate Nutrition 0.000 description 7
239000003642 reactive oxygen metabolite Substances 0.000 description 7
241000894007 species Species 0.000 description 7
238000013112 stability test Methods 0.000 description 7
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 6
244000089326 Polygonum longisetum Species 0.000 description 6
229910052799 carbon Inorganic materials 0.000 description 6
239000008367 deionised water Substances 0.000 description 6
229910021641 deionized water Inorganic materials 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
229940118019 malondialdehyde Drugs 0.000 description 6
210000003540 papillary muscle Anatomy 0.000 description 6
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
239000010452 phosphate Substances 0.000 description 6
239000011541 reaction mixture Substances 0.000 description 6
241000233839 Commelina communis Species 0.000 description 5
240000007171 Imperata cylindrica Species 0.000 description 5
RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 description 5
241000700159 Rattus Species 0.000 description 5
244000042324 Trifolium repens Species 0.000 description 5
235000010729 Trifolium repens Nutrition 0.000 description 5
241000233948 Typha Species 0.000 description 5
230000002195 synergetic effect Effects 0.000 description 5
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
235000004977 Brassica sinapistrum Nutrition 0.000 description 4
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 4
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
206010061216 Infarction Diseases 0.000 description 4
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 description 4
241000283973 Oryctolagus cuniculus Species 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
239000000654 additive Substances 0.000 description 4
235000019270 ammonium chloride Nutrition 0.000 description 4
244000030166 artemisia Species 0.000 description 4
229940009098 aspartate Drugs 0.000 description 4
229960004203 carnitine Drugs 0.000 description 4
244000038559 crop plants Species 0.000 description 4
239000013530 defoamer Substances 0.000 description 4
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 4
230000009467 reduction Effects 0.000 description 4
230000009182 swimming Effects 0.000 description 4
230000005945 translocation Effects 0.000 description 4
ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical class [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 3
241000219318 Amaranthus Species 0.000 description 3
235000003826 Artemisia Nutrition 0.000 description 3
235000003261 Artemisia vulgaris Nutrition 0.000 description 3
KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
241000611157 Brachiaria Species 0.000 description 3
235000014698 Brassica juncea var multisecta Nutrition 0.000 description 3
235000006008 Brassica napus var napus Nutrition 0.000 description 3
241000207892 Convolvulus Species 0.000 description 3
244000085625 Equisetum Species 0.000 description 3
241001071608 Erodium Species 0.000 description 3
241000520028 Lamium Species 0.000 description 3
240000000982 Malva neglecta Species 0.000 description 3
241000069499 Ottochloa Species 0.000 description 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
235000014676 Phragmites communis Nutrition 0.000 description 3
241001092459 Rubus Species 0.000 description 3
241000219053 Rumex Species 0.000 description 3
241000219793 Trifolium Species 0.000 description 3
229930003427 Vitamin E Natural products 0.000 description 3
240000008042 Zea mays Species 0.000 description 3
230000002411 adverse Effects 0.000 description 3
OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 3
150000001412 amines Chemical class 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
235000009052 artemisia Nutrition 0.000 description 3
TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 3
235000013734 beta-carotene Nutrition 0.000 description 3
239000011648 beta-carotene Substances 0.000 description 3
229960002747 betacarotene Drugs 0.000 description 3
239000005515 coenzyme Substances 0.000 description 3
230000007423 decrease Effects 0.000 description 3
SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 3
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
230000003902 lesion Effects 0.000 description 3
230000003859 lipid peroxidation Effects 0.000 description 3
229920001296 polysiloxane Polymers 0.000 description 3
150000003242 quaternary ammonium salts Chemical class 0.000 description 3
238000003756 stirring Methods 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
235000019165 vitamin E Nutrition 0.000 description 3
229940046009 vitamin E Drugs 0.000 description 3
239000011709 vitamin E Substances 0.000 description 3
OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 3
241001071161 Asclepias Species 0.000 description 2
235000007320 Avena fatua Nutrition 0.000 description 2
244000075850 Avena orientalis Species 0.000 description 2
241000047982 Axonopus Species 0.000 description 2
241000589968 Borrelia Species 0.000 description 2
241000339490 Brachyachne Species 0.000 description 2
241000219198 Brassica Species 0.000 description 2
235000011331 Brassica Nutrition 0.000 description 2
244000178993 Brassica juncea Species 0.000 description 2
235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 2
244000188595 Brassica sinapistrum Species 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
241000233838 Commelina Species 0.000 description 2
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
235000017896 Digitaria Nutrition 0.000 description 2
241001303487 Digitaria <clam> Species 0.000 description 2
241000208818 Helianthus Species 0.000 description 2
241000207783 Ipomoea Species 0.000 description 2
235000021506 Ipomoea Nutrition 0.000 description 2
241000110847 Kochia Species 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
235000009193 Lamium purpureum Nutrition 0.000 description 2
240000006503 Lamium purpureum Species 0.000 description 2
244000100545 Lolium multiflorum Species 0.000 description 2
240000004296 Lolium perenne Species 0.000 description 2
208000016604 Lyme disease Diseases 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
235000013939 Malva Nutrition 0.000 description 2
235000000060 Malva neglecta Nutrition 0.000 description 2
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
241000878007 Miscanthus Species 0.000 description 2
241001074119 Miscanthus sacchariflorus Species 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
QWYFHHGCZUCMBN-SECBINFHSA-N O-butanoyl-L-carnitine Chemical compound CCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C QWYFHHGCZUCMBN-SECBINFHSA-N 0.000 description 2
VSNFQQXVMPSASB-SNVBAGLBSA-N O-valeroyl-L-carnitine Chemical compound CCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C VSNFQQXVMPSASB-SNVBAGLBSA-N 0.000 description 2
HZYITADFUYMGSN-UHFFFAOYSA-N OS(CS(O)(=O)=O)(=O)=O.[SeH2] Chemical compound OS(CS(O)(=O)=O)(=O)=O.[SeH2] HZYITADFUYMGSN-UHFFFAOYSA-N 0.000 description 2
240000007594 Oryza sativa Species 0.000 description 2
235000007164 Oryza sativa Nutrition 0.000 description 2
241001330453 Paspalum Species 0.000 description 2
241000745991 Phalaris Species 0.000 description 2
244000273256 Phragmites communis Species 0.000 description 2
241000205407 Polygonum Species 0.000 description 2
241000219295 Portulaca Species 0.000 description 2
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
241000219780 Pueraria Species 0.000 description 2
241001632050 Salsola Species 0.000 description 2
241000780602 Senecio Species 0.000 description 2
235000005775 Setaria Nutrition 0.000 description 2
241000232088 Setaria <nematode> Species 0.000 description 2
241000607059 Solidago Species 0.000 description 2
241000209072 Sorghum Species 0.000 description 2
235000011684 Sorghum saccharatum Nutrition 0.000 description 2
DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 2
235000010730 Ulex europaeus Nutrition 0.000 description 2
240000003864 Ulex europaeus Species 0.000 description 2
229930003268 Vitamin C Natural products 0.000 description 2
241001506766 Xanthium Species 0.000 description 2
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
235000002017 Zea mays subsp mays Nutrition 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000009471 action Effects 0.000 description 2
230000000996 additive effect Effects 0.000 description 2
AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
229960003237 betaine Drugs 0.000 description 2
230000000747 cardiac effect Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
QZXCCPZJCKEPSA-UHFFFAOYSA-N chlorfenac Chemical compound OC(=O)CC1=C(Cl)C=CC(Cl)=C1Cl QZXCCPZJCKEPSA-UHFFFAOYSA-N 0.000 description 2
ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
235000005822 corn Nutrition 0.000 description 2
230000006378 damage Effects 0.000 description 2
239000003599 detergent Substances 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
238000001035 drying Methods 0.000 description 2
239000003995 emulsifying agent Substances 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
206010016256 fatigue Diseases 0.000 description 2
238000009661 fatigue test Methods 0.000 description 2
230000005484 gravity Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
PHFDTSRDEZEOHG-UHFFFAOYSA-N hydron;octan-1-amine;chloride Chemical compound Cl.CCCCCCCCN PHFDTSRDEZEOHG-UHFFFAOYSA-N 0.000 description 2
IGQBPDJNUXPEMT-SNVBAGLBSA-N isovaleryl-L-carnitine Chemical compound CC(C)CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C IGQBPDJNUXPEMT-SNVBAGLBSA-N 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
239000011777 magnesium Substances 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
QYPPRTNMGCREIM-UHFFFAOYSA-N methylarsonic acid Chemical compound C[As](O)(O)=O QYPPRTNMGCREIM-UHFFFAOYSA-N 0.000 description 2
208000010125 myocardial infarction Diseases 0.000 description 2
210000001087 myotubule Anatomy 0.000 description 2
FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
229950007002 phosphocreatine Drugs 0.000 description 2
239000000047 product Substances 0.000 description 2
231100000161 signs of toxicity Toxicity 0.000 description 2
AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 2
230000035882 stress Effects 0.000 description 2
229940095064 tartrate Drugs 0.000 description 2
XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
229960000278 theophylline Drugs 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
229940066528 trichloroacetate Drugs 0.000 description 2
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
235000019154 vitamin C Nutrition 0.000 description 2
239000011718 vitamin C Substances 0.000 description 2
GXEKYRXVRROBEV-FBXFSONDSA-N (1r,2s,3r,4s)-7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid Chemical compound C1C[C@@H]2[C@@H](C(O)=O)[C@@H](C(=O)O)[C@H]1O2 GXEKYRXVRROBEV-FBXFSONDSA-N 0.000 description 1
XZIDTOHMJBOSOX-UHFFFAOYSA-N 2,3,6-TBA Chemical compound OC(=O)C1=C(Cl)C=CC(Cl)=C1Cl XZIDTOHMJBOSOX-UHFFFAOYSA-N 0.000 description 1
239000002794 2,4-DB Substances 0.000 description 1
239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
MZHCENGPTKEIGP-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=C(Cl)C=C1Cl MZHCENGPTKEIGP-UHFFFAOYSA-N 0.000 description 1
WNTGYJSOUMFZEP-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=C(Cl)C=C1C WNTGYJSOUMFZEP-UHFFFAOYSA-N 0.000 description 1
KFEFNHNXZQYTEW-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-4-methylbenzoic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=CC(C)=CC=C1C(O)=O KFEFNHNXZQYTEW-UHFFFAOYSA-N 0.000 description 1
NUPJIGQFXCQJBK-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid Chemical compound OC(=O)C1=CC(COC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 NUPJIGQFXCQJBK-UHFFFAOYSA-N 0.000 description 1
CLQMBPJKHLGMQK-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)nicotinic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC=CC=C1C(O)=O CLQMBPJKHLGMQK-UHFFFAOYSA-N 0.000 description 1
GOCUAJYOYBLQRH-UHFFFAOYSA-N 2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC=C(C(F)(F)F)C=C1Cl GOCUAJYOYBLQRH-UHFFFAOYSA-N 0.000 description 1
YUVKUEAFAVKILW-UHFFFAOYSA-N 2-(4-{[5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 YUVKUEAFAVKILW-UHFFFAOYSA-N 0.000 description 1
OOLBCHYXZDXLDS-UHFFFAOYSA-N 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=CC=C(Cl)C=C1Cl OOLBCHYXZDXLDS-UHFFFAOYSA-N 0.000 description 1
MPPOHAUSNPTFAJ-UHFFFAOYSA-N 2-[4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1OC1=NC2=CC=C(Cl)C=C2O1 MPPOHAUSNPTFAJ-UHFFFAOYSA-N 0.000 description 1
CABMTIJINOIHOD-UHFFFAOYSA-N 2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]quinoline-3-carboxylic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC2=CC=CC=C2C=C1C(O)=O CABMTIJINOIHOD-UHFFFAOYSA-N 0.000 description 1
HVYJSOSGTDINLW-UHFFFAOYSA-N 2-[dimethyl(octadecyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O HVYJSOSGTDINLW-UHFFFAOYSA-N 0.000 description 1
LLWADFLAOKUBDR-UHFFFAOYSA-N 2-methyl-4-chlorophenoxybutyric acid Chemical compound CC1=CC(Cl)=CC=C1OCCCC(O)=O LLWADFLAOKUBDR-UHFFFAOYSA-N 0.000 description 1
RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
UPMXNNIRAGDFEH-UHFFFAOYSA-N 3,5-dibromo-4-hydroxybenzonitrile Chemical compound OC1=C(Br)C=C(C#N)C=C1Br UPMXNNIRAGDFEH-UHFFFAOYSA-N 0.000 description 1
CTSLUCNDVMMDHG-UHFFFAOYSA-N 5-bromo-3-(butan-2-yl)-6-methylpyrimidine-2,4(1H,3H)-dione Chemical compound CCC(C)N1C(=O)NC(C)=C(Br)C1=O CTSLUCNDVMMDHG-UHFFFAOYSA-N 0.000 description 1
PVSGXWMWNRGTKE-UHFFFAOYSA-N 5-methyl-2-[4-methyl-5-oxo-4-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]pyridine-3-carboxylic acid Chemical compound N1C(=O)C(C(C)C)(C)N=C1C1=NC=C(C)C=C1C(O)=O PVSGXWMWNRGTKE-UHFFFAOYSA-N 0.000 description 1
241000219144 Abutilon Species 0.000 description 1
240000006995 Abutilon theophrasti Species 0.000 description 1
235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 1
108010053481 Antifreeze Proteins Proteins 0.000 description 1
235000017519 Artemisia princeps Nutrition 0.000 description 1
244000065027 Artemisia princeps Species 0.000 description 1
240000006891 Artemisia vulgaris Species 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
235000005781 Avena Nutrition 0.000 description 1
241000209764 Avena fatua Species 0.000 description 1
239000005476 Bentazone Substances 0.000 description 1
235000008427 Brassica arvensis Nutrition 0.000 description 1
244000024671 Brassica kaber Species 0.000 description 1
240000002791 Brassica napus Species 0.000 description 1
235000011292 Brassica rapa Nutrition 0.000 description 1
239000005489 Bromoxynil Substances 0.000 description 1
241000209200 Bromus Species 0.000 description 1
241000209202 Bromus secalinus Species 0.000 description 1
241001148727 Bromus tectorum Species 0.000 description 1
GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
244000025254 Cannabis sativa Species 0.000 description 1
241000722731 Carex Species 0.000 description 1
244000103926 Chamaenerion angustifolium Species 0.000 description 1
235000006890 Chamerion angustifolium subsp angustifolium Nutrition 0.000 description 1
235000002278 Chamerion angustifolium subsp circumvagum Nutrition 0.000 description 1
241000219312 Chenopodium Species 0.000 description 1
244000281762 Chenopodium ambrosioides Species 0.000 description 1
HSSBORCLYSCBJR-UHFFFAOYSA-N Chloramben Chemical compound NC1=CC(Cl)=CC(C(O)=O)=C1Cl HSSBORCLYSCBJR-UHFFFAOYSA-N 0.000 description 1
241000132536 Cirsium Species 0.000 description 1
235000005918 Cirsium arvense Nutrition 0.000 description 1
240000001579 Cirsium arvense Species 0.000 description 1
241000207894 Convolvulus arvensis Species 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
102000004420 Creatine Kinase Human genes 0.000 description 1
108010042126 Creatine kinase Proteins 0.000 description 1
241000234653 Cyperus Species 0.000 description 1
244000285774 Cyperus esculentus Species 0.000 description 1
235000005853 Cyperus esculentus Nutrition 0.000 description 1
244000075634 Cyperus rotundus Species 0.000 description 1
NDUPDOJHUQKPAG-UHFFFAOYSA-N Dalapon Chemical compound CC(Cl)(Cl)C(O)=O NDUPDOJHUQKPAG-UHFFFAOYSA-N 0.000 description 1
239000005506 Diclofop Substances 0.000 description 1
240000004551 Drosera rotundifolia Species 0.000 description 1
241000192043 Echinochloa Species 0.000 description 1
244000058871 Echinochloa crus-galli Species 0.000 description 1
241000209215 Eleusine Species 0.000 description 1
235000007351 Eleusine Nutrition 0.000 description 1
235000014716 Eleusine indica Nutrition 0.000 description 1
244000025670 Eleusine indica Species 0.000 description 1
241000744304 Elymus Species 0.000 description 1
241000508725 Elymus repens Species 0.000 description 1
241000195955 Equisetum hyemale Species 0.000 description 1
244000207543 Euphorbia heterophylla Species 0.000 description 1
244000248416 Fagopyrum cymosum Species 0.000 description 1
235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
240000008620 Fagopyrum esculentum Species 0.000 description 1
YQVMVCCFZCMYQB-UHFFFAOYSA-N Flamprop Chemical compound C=1C=C(F)C(Cl)=CC=1N(C(C)C(O)=O)C(=O)C1=CC=CC=C1 YQVMVCCFZCMYQB-UHFFFAOYSA-N 0.000 description 1
DHAHEVIQIYRFRG-UHFFFAOYSA-N Fluoroglycofen Chemical compound C1=C([N+]([O-])=O)C(C(=O)OCC(=O)O)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 DHAHEVIQIYRFRG-UHFFFAOYSA-N 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
241000219146 Gossypium Species 0.000 description 1
206010019280 Heart failures Diseases 0.000 description 1
244000020551 Helianthus annuus Species 0.000 description 1
239000005566 Imazamox Substances 0.000 description 1
239000005981 Imazaquin Substances 0.000 description 1
XVOKUMIPKHGGTN-UHFFFAOYSA-N Imazethapyr Chemical compound OC(=O)C1=CC(CC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 XVOKUMIPKHGGTN-UHFFFAOYSA-N 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
240000001549 Ipomoea eriocarpa Species 0.000 description 1
241000209082 Lolium Species 0.000 description 1
239000005574 MCPA Substances 0.000 description 1
239000005575 MCPB Substances 0.000 description 1
101150039283 MCPB gene Proteins 0.000 description 1
239000005913 Maltodextrin Substances 0.000 description 1
229920002774 Maltodextrin Polymers 0.000 description 1
PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
240000007298 Megathyrsus maximus Species 0.000 description 1
241000878006 Miscanthus sinensis Species 0.000 description 1
208000010428 Muscle Weakness Diseases 0.000 description 1
206010028372 Muscular weakness Diseases 0.000 description 1
108010044370 Oraza Proteins 0.000 description 1
241000283977 Oryctolagus Species 0.000 description 1
241000209117 Panicum Species 0.000 description 1
235000011999 Panicum crusgalli Nutrition 0.000 description 1
235000006443 Panicum miliaceum subsp. miliaceum Nutrition 0.000 description 1
235000009037 Panicum miliaceum subsp. ruderale Nutrition 0.000 description 1
241001268782 Paspalum dilatatum Species 0.000 description 1
241001330451 Paspalum notatum Species 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
239000005595 Picloram Substances 0.000 description 1
244000234609 Portulaca oleracea Species 0.000 description 1
241001453830 Pteridium Species 0.000 description 1
235000009936 Pteridium aquilinum Nutrition 0.000 description 1
240000005893 Pteridium aquilinum Species 0.000 description 1
235000010575 Pueraria lobata Nutrition 0.000 description 1
244000046146 Pueraria lobata Species 0.000 description 1
235000016554 Rubus chamaemorus Nutrition 0.000 description 1
240000006831 Rubus chamaemorus Species 0.000 description 1
235000009422 Rumex obtusifolius Nutrition 0.000 description 1
240000007113 Rumex obtusifolius Species 0.000 description 1
240000002625 Salsola soda Species 0.000 description 1
240000003705 Senecio vulgaris Species 0.000 description 1
241001302210 Sida <water flea> Species 0.000 description 1
241000220261 Sinapis Species 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
235000002594 Solanum nigrum Nutrition 0.000 description 1
244000061457 Solanum nigrum Species 0.000 description 1
240000002439 Sorghum halepense Species 0.000 description 1
244000299461 Theobroma cacao Species 0.000 description 1
235000009470 Theobroma cacao Nutrition 0.000 description 1
WHKUVVPPKQRRBV-UHFFFAOYSA-N Trasan Chemical compound CC1=CC(Cl)=CC=C1OCC(O)=O WHKUVVPPKQRRBV-UHFFFAOYSA-N 0.000 description 1
239000005627 Triclopyr Substances 0.000 description 1
235000019714 Triticale Nutrition 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
244000098338 Triticum aestivum Species 0.000 description 1
241000219871 Ulex Species 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
235000005373 Uvularia sessilifolia Nutrition 0.000 description 1
241000209149 Zea Species 0.000 description 1
235000007244 Zea mays Nutrition 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
NUFNQYOELLVIPL-UHFFFAOYSA-N acifluorfen Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 NUFNQYOELLVIPL-UHFFFAOYSA-N 0.000 description 1
RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 1
229940024606 amino acid Drugs 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000002280 amphoteric surfactant Substances 0.000 description 1
239000003945 anionic surfactant Substances 0.000 description 1
235000003484 annual ragweed Nutrition 0.000 description 1
230000002528 anti-freeze Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
VGPYEHKOIGNJKV-UHFFFAOYSA-N asulam Chemical compound COC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VGPYEHKOIGNJKV-UHFFFAOYSA-N 0.000 description 1
238000011888 autopsy Methods 0.000 description 1
OTSAMNSACVKIOJ-UHFFFAOYSA-N azane;carbamoyl(ethoxy)phosphinic acid Chemical compound [NH4+].CCOP([O-])(=O)C(N)=O OTSAMNSACVKIOJ-UHFFFAOYSA-N 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
ZOMSMJKLGFBRBS-UHFFFAOYSA-N bentazone Chemical compound C1=CC=C2NS(=O)(=O)N(C(C)C)C(=O)C2=C1 ZOMSMJKLGFBRBS-UHFFFAOYSA-N 0.000 description 1
CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzidamine Natural products C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 description 1
GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
238000004820 blood count Methods 0.000 description 1
235000006263 bur ragweed Nutrition 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
235000013877 carbamide Nutrition 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003086 colorant Substances 0.000 description 1
235000003488 common ragweed Nutrition 0.000 description 1
238000005260 corrosion Methods 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000000994 depressogenic effect Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
230000037149 energy metabolism Effects 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000003337 fertilizer Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
BGZZWXTVIYUUEY-UHFFFAOYSA-N fomesafen Chemical compound C1=C([N+]([O-])=O)C(C(=O)NS(=O)(=O)C)=CC(OC=2C(=CC(=CC=2)C(F)(F)F)Cl)=C1 BGZZWXTVIYUUEY-UHFFFAOYSA-N 0.000 description 1
HIPLEPXPNLWKCQ-UHFFFAOYSA-N fosfocreatinine Chemical compound CN1CC(=O)N=C1NP(O)(O)=O HIPLEPXPNLWKCQ-UHFFFAOYSA-N 0.000 description 1
229940025237 fructose 1,6-diphosphate Drugs 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
230000001744 histochemical effect Effects 0.000 description 1
239000008240 homogeneous mixture Substances 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
NRXQIUSYPAHGNM-UHFFFAOYSA-N ioxynil Chemical compound OC1=C(I)C=C(C#N)C=C1I NRXQIUSYPAHGNM-UHFFFAOYSA-N 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
159000000003 magnesium salts Chemical class 0.000 description 1
229940035034 maltodextrin Drugs 0.000 description 1
239000011572 manganese Substances 0.000 description 1
229910052748 manganese Inorganic materials 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000000873 masking effect Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
NDNKHWUXXOFHTD-UHFFFAOYSA-N metizoline Chemical compound CC=1SC2=CC=CC=C2C=1CC1=NCCN1 NDNKHWUXXOFHTD-UHFFFAOYSA-N 0.000 description 1
229960002939 metizoline Drugs 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004220 muscle function Effects 0.000 description 1
230000002107 myocardial effect Effects 0.000 description 1
208000031225 myocardial ischemia Diseases 0.000 description 1
LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
DZJFABDVWIPEIM-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)dodecan-1-amine oxide Chemical class CCCCCCCCCCCC[N+]([O-])(CCO)CCO DZJFABDVWIPEIM-UHFFFAOYSA-N 0.000 description 1
PJLIBHKZIIDANT-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)octan-1-amine oxide Chemical class CCCCCCCC[N+]([O-])(CCO)CCO PJLIBHKZIIDANT-UHFFFAOYSA-N 0.000 description 1
UTTVXKGNTWZECK-UHFFFAOYSA-N n,n-dimethyloctadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)[O-] UTTVXKGNTWZECK-UHFFFAOYSA-N 0.000 description 1
DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
JXTHEWSKYLZVJC-UHFFFAOYSA-N naptalam Chemical compound OC(=O)C1=CC=CC=C1C(=O)NC1=CC=CC2=CC=CC=C12 JXTHEWSKYLZVJC-UHFFFAOYSA-N 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000007800 oxidant agent Substances 0.000 description 1
230000036542 oxidative stress Effects 0.000 description 1
230000036284 oxygen consumption Effects 0.000 description 1
230000007310 pathophysiology Effects 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000003285 pharmacodynamic effect Effects 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
NQQVFXUMIDALNH-UHFFFAOYSA-N picloram Chemical compound NC1=C(Cl)C(Cl)=NC(C(O)=O)=C1Cl NQQVFXUMIDALNH-UHFFFAOYSA-N 0.000 description 1
239000000049 pigment Substances 0.000 description 1
230000008635 plant growth Effects 0.000 description 1
239000001103 potassium chloride Substances 0.000 description 1
235000011164 potassium chloride Nutrition 0.000 description 1
OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
229910052939 potassium sulfate Inorganic materials 0.000 description 1
235000011151 potassium sulphates Nutrition 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
235000009736 ragweed Nutrition 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
230000006950 reactive oxygen species formation Effects 0.000 description 1
230000033458 reproduction Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
230000011667 skeletal muscle adaptation Effects 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
230000037078 sports performance Effects 0.000 description 1
235000020354 squash Nutrition 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
230000003319 supportive effect Effects 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229960003080 taurine Drugs 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000002110 toxicologic effect Effects 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
REEQLXCGVXDJSQ-UHFFFAOYSA-N trichlopyr Chemical compound OC(=O)COC1=NC(Cl)=C(Cl)C=C1Cl REEQLXCGVXDJSQ-UHFFFAOYSA-N 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
241000228158 x Triticosecale Species 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

CZ20023A 1999-07-23 2000-07-21 Kombinovaný přípravek k prevenci svalové únavy a přizpůsobení kosterního svalstva na vyčerpávající výkony CZ20023A3 (cs)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT1999RM000467A IT1306173B1 (it)	1999-07-23	1999-07-23	Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.

Publications (1)

Publication Number	Publication Date
CZ20023A3 true CZ20023A3 (cs)	2002-06-12

Family

ID=11406897

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CZ20023A CZ20023A3 (cs)	1999-07-23	2000-07-21	Kombinovaný přípravek k prevenci svalové únavy a přizpůsobení kosterního svalstva na vyčerpávající výkony

Country Status (21)

Country	Link
US (1)	US6602512B1 (de)
EP (1)	EP1196046B1 (de)
AR (1)	AR024820A1 (de)
AT (1)	ATE263496T1 (de)
AU (1)	AU778647B2 (de)
CA (1)	CA2377128C (de)
CZ (1)	CZ20023A3 (de)
DE (1)	DE60009704T2 (de)
DK (1)	DK1196046T3 (de)
ES (1)	ES2216931T3 (de)
HU (1)	HU228838B1 (de)
IL (1)	IL147408A0 (de)
IT (1)	IT1306173B1 (de)
MX (1)	MXPA02000780A (de)
NO (1)	NO20020337L (de)
PL (1)	PL204743B1 (de)
PT (1)	PT1196046E (de)
SK (1)	SK942002A3 (de)
TN (1)	TNSN00161A1 (de)
TR (1)	TR200200179T2 (de)
WO (1)	WO2001006873A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1316998B1 (it) *	2000-03-02	2003-05-26	Sigma Tau Healthscience Spa	Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
US7449451B2 (en) *	2001-08-29	2008-11-11	Premier Micronutrient Corporation	Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks
US6849613B2 (en)	2001-08-29	2005-02-01	Kedar N. Prasad	Multiple antioxidant micronutrients
DE10160485A1 (de) *	2001-12-08	2003-10-02	Degussa	Verwendung von Kreatin und/oder einem seiner physiologisch geeigneten Derivate zur Prävention oder Linderung von nicht krankheitsbedingten Beeinträchtigungen und/oder Störungen der Muskelfunktion
DE102004009962A1 (de) *	2004-03-01	2005-09-22	Degussa Ag	Verwendung von Guanidin-Verbindungen als physiologisches Stärkungsmittel in Form von Nahrungsergänzungsmitteln, Futtermittelzusätzen, in kosmetischen Zubereitungen und als Pflanzenstärkungsmittel
US20060083793A1 (en) *	2004-09-29	2006-04-20	Gardiner Paul T	Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker
AU2006269779A1 (en) *	2005-07-07	2007-01-18	H3 Formulations Ltd.	Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells
GB0606864D0 (en) *	2006-04-05	2006-05-17	Univ Nottingham	Increades fatty acid oxidation
AU2006347819A1 (en) *	2006-08-30	2008-03-06	Aplodan Formulations Ltd.	Increasing ATP availability by inhibition of Creatine Kinase (CK) leakage resulting from high-intensity exercise
US7368441B2 (en) *	2006-08-30	2008-05-06	Aplodan Formulations Ltd.	Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
WO2008025115A1 (en) *	2006-08-30	2008-03-06	Aplodan Formulations Ltd.	Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
US7375097B2 (en) *	2006-08-30	2008-05-20	Aplodan Formulations Ltd.	Increasing ATP availability by inhibition of creatine kinase (CK) leakage resulting from high-intensity exercise
US20100124587A1 (en) *	2008-11-17	2010-05-20	Heuer Marvin A	Creatine-containing vitamin and mineral composition
US20110105786A1 (en) *	2009-11-02	2011-05-05	Tianjin Tiancheng Pharmaceutical Co., Ltd.	Creatinol o-phosphate and synthesis method thereof
RU2623878C2 (ru)	2010-12-10	2017-06-29	Броади Хэлс Сайенсис, Эл Эл Си	Применение жасмоната для лечения нарушения функции мочевого пузыря
US10016382B2 (en)	2014-06-12	2018-07-10	Lonza Inc.	Method for decreasing skeletal muscle damage and/or oxidative stress in mammals
US10499682B2 (en)	2014-08-25	2019-12-10	New Age Beverage Corporation	Micronutrient formulation in electronic cigarettes
BR112018007434A2 (pt)	2015-10-27	2018-10-23	Cytozyme Animal Nutrition Inc	composições para nutrição animal, usos e métodos relacionados
US10674746B2 (en)	2015-10-27	2020-06-09	Cytozyme Animal Nutrition, Inc.	Animal nutrition compositions and related methods
CA3008033A1 (en)	2015-12-18	2017-06-22	Lonza, Inc.	Method and composition for increasing muscle protein synthesis and/or functional strength in mammals
WO2022215085A1 (en)	2021-04-06	2022-10-13	Celagenex Research (India) Pvt. Ltd.	A synergistic composition for potentiating stabilized atp

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU518617B2 (en) *	1977-04-29	1981-10-08	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Therapeutic application of acetyl-d, 1-carnitine
IT1124697B (it) *	1979-10-26	1986-05-14	Simes	Derivati di creatinolo o-fosfato ad azione terapeutica,procedimento per la sua preparazione e relativ-e composizioni farmaceutiche
US6080788A (en) *	1997-03-27	2000-06-27	Sole; Michael J.	Composition for improvement of cellular nutrition and mitochondrial energetics
IT1291127B1 (it) *	1997-04-01	1998-12-29	Sigma Tau Ind Farmaceuti	Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
EP0891719A1 (de) *	1997-07-14	1999-01-20	N.V. Nutricia	Narungszusammensetzungen mit Gehalt an Methionin
AU759467B2 (en)	1998-04-02	2003-04-17	Avicena Group, Inc.	Compositions containing a combination of a creatine compound and a second agent
ES2146555B1 (es) *	1999-01-22	2001-03-01	Helsint S A L	Empleo de formulaciones a base de fracciones hidrosolubles de phlebodium decumanum (exply-37) y/o polypodium leucotomos como complemento nutricional en la prevencion y reversion del sindrome de sobresfuerzo fisico.

1999
- 1999-07-23 IT IT1999RM000467A patent/IT1306173B1/it active
2000
- 2000-07-21 TR TR2002/00179T patent/TR200200179T2/xx unknown
- 2000-07-21 DE DE60009704T patent/DE60009704T2/de not_active Expired - Lifetime
- 2000-07-21 CZ CZ20023A patent/CZ20023A3/cs unknown
- 2000-07-21 TN TNTNSN00161A patent/TNSN00161A1/fr unknown
- 2000-07-21 AU AU64687/00A patent/AU778647B2/en not_active Ceased
- 2000-07-21 PL PL352683A patent/PL204743B1/pl unknown
- 2000-07-21 SK SK94-2002A patent/SK942002A3/sk unknown
- 2000-07-21 IL IL14740800A patent/IL147408A0/xx unknown
- 2000-07-21 US US10/019,546 patent/US6602512B1/en not_active Expired - Lifetime
- 2000-07-21 HU HU0202298A patent/HU228838B1/hu not_active IP Right Cessation
- 2000-07-21 EP EP00951844A patent/EP1196046B1/de not_active Expired - Lifetime
- 2000-07-21 AR ARP000103777A patent/AR024820A1/es unknown
- 2000-07-21 CA CA002377128A patent/CA2377128C/en not_active Expired - Lifetime
- 2000-07-21 PT PT00951844T patent/PT1196046E/pt unknown
- 2000-07-21 MX MXPA02000780A patent/MXPA02000780A/es active IP Right Grant
- 2000-07-21 DK DK00951844T patent/DK1196046T3/da active
- 2000-07-21 WO PCT/IT2000/000308 patent/WO2001006873A1/en not_active Ceased
- 2000-07-21 ES ES00951844T patent/ES2216931T3/es not_active Expired - Lifetime
- 2000-07-21 AT AT00951844T patent/ATE263496T1/de active
2002
- 2002-01-22 NO NO20020337A patent/NO20020337L/no unknown

Also Published As

Publication number	Publication date
CA2377128A1 (en)	2001-02-01
HU228838B1 (en)	2013-06-28
TR200200179T2 (tr)	2002-06-21
DK1196046T3 (da)	2004-08-02
EP1196046A1 (de)	2002-04-17
TNSN00161A1 (fr)	2005-11-10
AU6468700A (en)	2001-02-13
WO2001006873A1 (en)	2001-02-01
AU778647B2 (en)	2004-12-16
CA2377128C (en)	2009-09-22
DE60009704T2 (de)	2005-04-14
NO20020337L (no)	2002-03-22
PL352683A1 (en)	2003-09-08
ATE263496T1 (de)	2004-04-15
HUP0202298A3 (en)	2005-07-28
IT1306173B1 (it)	2001-05-30
IL147408A0 (en)	2002-08-14
US6602512B1 (en)	2003-08-05
NO20020337D0 (no)	2002-01-22
ITRM990467A0 (it)	1999-07-23
MXPA02000780A (es)	2002-08-20
DE60009704D1 (de)	2004-05-13
HUP0202298A2 (en)	2002-10-28
ITRM990467A1 (it)	2001-01-23
EP1196046B1 (de)	2004-04-07
AR024820A1 (es)	2002-10-23
ES2216931T3 (es)	2004-11-01
PT1196046E (pt)	2004-08-31
SK942002A3 (en)	2002-05-09
PL204743B1 (pl)	2010-02-26

Publication	Publication Date	Title
CZ20023A3 (cs)	2002-06-12	Kombinovaný přípravek k prevenci svalové únavy a přizpůsobení kosterního svalstva na vyčerpávající výkony
AU732689B2 (en)	2001-04-26	High-loaded ammonium glyphosate formulations
EP1202623B1 (de)	2004-09-22	Verbesserte herbizidzusammensetzunen
ES2269409T3 (es)	2007-04-01	Formulaciones pesticidas acuosas y nuevos tensioactivos.
ES2228161T3 (es)	2005-04-01	Composiciones de glifosato acuoso altamente concentradas.
US9596847B2 (en)	2017-03-21	Alkoxylated alkylamine quaternary surfactants for glyphosate
CA2383746C (en)	2009-11-17	Enhanced method of killing weeds with glyphosate herbicide
BR0012978B1 (pt)	2012-11-27	composição de microemulsão herbicida concentrada lìquida e processo para aniquilar ou controlar plantas indesejadas.
US6500783B1 (en)	2002-12-31	Process and compositions promoting biological effectiveness of exogenous chemical substances in plants
MXPA01006571A (es)	2001-12-01	Procedimiento y composiciones para promover efectividad biologica de sustancias quimicas exogenas en plan
WO1998053680A1 (en)	1998-12-03	Process and compositions promoting biological effectiveness of exogenous chemical substances in plants
MXPA00000889A (en)	2001-12-13	High-loaded ammonium glyphosate formulations